0
0
Read Time:9 Second
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 07, 2025, titled “Zydus receives tentative approval from USFDA for Olaparib Tablets, 100 mg and 150 mg”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %